AMATO, MARIA PIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.702
EU - Europa 19.002
AS - Asia 12.985
SA - Sud America 2.410
Continente sconosciuto - Info sul continente non disponibili 613
AF - Africa 364
OC - Oceania 295
Totale 66.371
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.124
RU - Federazione Russa 5.396
IT - Italia 4.941
SG - Singapore 3.586
CN - Cina 3.010
PL - Polonia 2.893
HK - Hong Kong 1.929
BR - Brasile 1.908
VN - Vietnam 1.436
IE - Irlanda 1.279
KR - Corea 1.229
SE - Svezia 1.075
FR - Francia 585
FI - Finlandia 556
DE - Germania 545
UA - Ucraina 448
IN - India 434
GB - Regno Unito 353
BE - Belgio 350
CA - Canada 342
BD - Bangladesh 304
AU - Australia 290
TR - Turchia 204
AR - Argentina 194
JP - Giappone 182
NL - Olanda 163
ID - Indonesia 140
ES - Italia 103
JO - Giordania 98
EC - Ecuador 94
MX - Messico 94
IQ - Iraq 82
CI - Costa d'Avorio 76
ZA - Sudafrica 70
CH - Svizzera 67
CO - Colombia 66
AT - Austria 50
NG - Nigeria 45
PK - Pakistan 44
PH - Filippine 43
IR - Iran 41
VE - Venezuela 39
CL - Cile 33
MA - Marocco 31
UZ - Uzbekistan 31
CZ - Repubblica Ceca 30
EG - Egitto 30
JM - Giamaica 30
PY - Paraguay 29
SC - Seychelles 29
PT - Portogallo 26
PE - Perù 23
SA - Arabia Saudita 22
MY - Malesia 19
HN - Honduras 18
KE - Kenya 18
AE - Emirati Arabi Uniti 17
MK - Macedonia 17
GR - Grecia 16
CR - Costa Rica 15
LT - Lituania 15
NP - Nepal 15
DZ - Algeria 14
IL - Israele 14
TN - Tunisia 14
TH - Thailandia 13
AZ - Azerbaigian 12
KZ - Kazakistan 12
RO - Romania 12
UY - Uruguay 12
GT - Guatemala 11
PA - Panama 11
RS - Serbia 11
BG - Bulgaria 10
BO - Bolivia 10
TT - Trinidad e Tobago 10
BH - Bahrain 9
DK - Danimarca 9
EU - Europa 9
NI - Nicaragua 9
OM - Oman 9
PR - Porto Rico 9
SK - Slovacchia (Repubblica Slovacca) 9
BJ - Benin 8
GE - Georgia 8
ET - Etiopia 7
AL - Albania 6
BB - Barbados 6
LB - Libano 6
TW - Taiwan 6
BY - Bielorussia 5
CY - Cipro 5
HR - Croazia 5
LK - Sri Lanka 5
LV - Lettonia 5
MD - Moldavia 5
NO - Norvegia 5
SV - El Salvador 5
DO - Repubblica Dominicana 4
HU - Ungheria 4
Totale 65.696
Salva come PNG Salva come JPEG
Città #
Santa Clara 4.775
Ashburn 3.285
Warsaw 2.871
Fairfield 2.862
Singapore 2.534
Hong Kong 1.597
Woodbridge 1.354
Dublin 1.266
Seoul 1.207
Cambridge 1.182
Seattle 1.173
San Jose 1.155
Chandler 1.121
Houston 1.077
Wilmington 934
Milan 913
Hefei 702
Jacksonville 666
Council Bluffs 638
Altamura 569
Beijing 547
Lawrence 543
Ho Chi Minh City 470
Princeton 442
Los Angeles 432
The Dalles 410
Ann Arbor 403
Buffalo 382
Lauterbourg 370
Rome 357
Moscow 309
Florence 282
Hanoi 280
Melbourne 273
Boston 269
Mumbai 253
New York 205
Helsinki 204
Boardman 203
Medford 196
Phoenix 184
Dallas 147
San Diego 147
Tokyo 147
São Paulo 146
Kent 143
Munich 137
Asse 132
Reet 132
Izmir 118
Turin 114
Naples 113
Shanghai 105
Bologna 96
Clifton 93
Paris 89
Toronto 77
Abidjan 76
Chicago 73
Norwalk 69
Jakarta 67
Brooklyn 64
Orem 64
Columbus 63
Haiphong 60
London 59
Palermo 59
Barcelona 57
Da Nang 57
Falls Church 57
Dearborn 54
Meise 54
Atlanta 52
Dong Ket 52
Figino 52
Redondo Beach 52
Miano 51
Rio de Janeiro 50
Turku 50
Montreal 49
Verona 49
Hillsboro 48
Chennai 47
Brasília 45
Genoa 45
Abuja 44
Frankfurt am Main 43
Guangzhou 43
Andover 42
West Jordan 42
Bari 41
Bern 41
Denver 41
Quito 40
Yubileyny 40
Catania 38
Belo Horizonte 36
Bengaluru 35
Biên Hòa 32
Brescia 32
Totale 42.996
Salva come PNG Salva come JPEG
Nome #
Multiple sclerosis progression: time for a new mechanism-driven framework 605
The effects of gamma-tACS on cognitive impairment in multiple sclerosis: A randomized, double-blind, sham-controlled, pilot study 536
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population. 488
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation. 476
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop 403
EPIDURAL ANALGESIA AND CESAREAN DELIVERY IN MULTIPLE SCLEROSIS POST PARTU RELAPSES: THE ITALIAN COHORT STUDY. 340
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 325
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. 318
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. 317
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. 313
Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis. 312
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis. 311
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 310
The Italian multiple sclerosis register. 307
MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients. 303
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS. 293
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 283
Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene. 282
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population. 271
Geographical variations in sex ratio trends over time in multiple sclerosis 270
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. 269
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial. 269
Radiologically isolated syndrome: 5-year risk for an initial clinical event. 264
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 256
Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab 254
THE RAO'S BRIEF REPEATABLE BATTERY AND STROOP TEST: NORMATIVE VALUES WITH AGE, EDUCATION AND GENDER CORRECTIONS IN AN ITALIAN POPULATION. 249
Anxiety state affects information processing speed in patients with multiple sclerosis. 248
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. 245
Identifying risk factors for cognitive issues in Multiple Sclerosis 234
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures. 232
Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment—A Literature Review 231
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: a phase II trial. 228
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors 228
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study 228
Assessing executive function with the D-KEFS sorting test: normative data for a sample of the Italian adult population. 226
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. 225
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon beta-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study. 225
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. 224
Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. 217
Cognitive impairment in early stages of multiple sclerosis. 215
Cognitive assessment in multiple sclerosis-an Italian consensus 215
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 214
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series 214
Cognitive impairment and event-related potentials in paediatric multiple sclerosis: 2-year study. 213
Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability 213
BRAIN DAMAGE AS DETECTED BY MAGNETIZATION TRANSFER IMAGING IS LESS PRONOUNCED IN BENIGN THAN IN EARLY RELAPSING MULTIPLE SCLEROSIS. 209
Multiple Sclerosis Progression and Relapse Activity in Children 206
Beyond Disease: Happiness, Goals, and Meanings among Persons with Multiple Sclerosis and Their Caregivers 204
Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial 203
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience 203
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 200
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 198
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 197
Impact of cognitive impairment on coping strategies in multiple sclerosis. 197
A case of Takotsubo syndrome during a multiple sclerosis brainstem relapse 197
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. 197
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis 195
Cognitive rehabilitation in children and adolescents with multiple sclerosis. 195
Cognitive impairment in multiple sclerosis: a longitudinal study 194
Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach 194
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. 193
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases. 192
Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support 191
Association of Neocortical Volume Changes with Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis 189
Changes in neuropsychological test performance over the workday in multiple sclerosis. 188
The clinical spectrum of anti-MOG associated acquired demyelinating disorders: Three case-reports 188
The World Health Organization cross-national research program on age-associated dementias. 186
Electronystagmography in the diagnosis of multiple sclerosis. 185
ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis. 185
MRI substrates of sustained attention system and cognitive impairment in pediatric MS patients 185
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study 185
NEOCORTICAL VOLUME DECREASE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS WITH MILD COGNITIVE IMPAIRMENT. 184
A prospective study on the prognosis of multiple sclerosis. 184
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes 184
Quality of life in multiple sclerosis: The impact of depression, fatigue and disability 183
RESPONSE TO INTERFERON-BETA THERAPY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A COMPARISON OF DIFFERENT CLINICAL CRITERIA. 181
Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis. 179
BENIGN MULTIPLE SCLEROSIS: COGNITIVE, PSYCHOLOGICAL AND SOCIAL ASPECTS IN A CLINICAL COHORT. 179
Emotional and neutral verbal memory impairment in Multiple Sclerosis. 179
Are there protective treatments for cognitive decline in MS? 177
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. 177
Cognitive and psychosocial features of childhood and juvenile MS. 177
Author response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 177
Cognitive impairment in multiple sclerosis. 176
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study 176
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis. 175
Impatto funzionale 174
Association of celiac disease in patients with multiple sclerosis in Tuscany 174
Cognitive changes in multiple sclerosis 173
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis. 173
Abnormal cerebellar functional MRI connectivity in patients with paediatric multiple sclerosis. 173
New natural history of interferon-b treated relapsing multiple sclerosis 172
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis 171
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 171
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 171
A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN. 170
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. 170
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs. 170
Cerebrospinal fluid igm and oligoclonal igg bands in multiple sclerosis: A meta-analysis of prevalence and prognosis 170
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 169
Totale 23.044
Salva come PNG Salva come JPEG
Categoria #
all - tutte 188.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 188.894
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.150 0 0 178 96 85 125 103 185 166 107 405 700
2022/20235.896 722 1.351 190 367 425 1.051 710 271 533 34 147 95
2023/20242.308 106 250 429 159 163 183 100 400 54 208 164 92
2024/202514.952 688 1.740 913 2.075 4.035 1.849 251 755 940 438 580 688
2025/202621.681 1.891 2.724 2.232 2.167 2.169 820 1.992 1.270 1.178 1.110 678 3.450
2026/20273.147 880 836 1.431 0 0 0 0 0 0 0 0 0
Totale 66.371